Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer
✍ Scribed by Jögi, Annika; Brennan, Donal J; Rydén, Lisa; Magnusson, Kristina; Fernö, Mårten; Stål, Olle; Borgquist, Signe; Uhlen, Mathias; Landberg, Göran; Påhlman, Sven
- Book ID
- 109887753
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 454 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0893-3952
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Recently, expression profiling of breast carcinomas has revealed gene signatures that predict clinical outcome, and discerned prognostically relevant breast cancer subtypes. Measurement of the degree of genomic instability provides a very similar stratification of prognostic groups. We
## Abstract We have reported previously that apigenin, a naturally occurring nonmutagenic flavonoid, increased wild‐type p53 protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization. Here we further demonstrated that the increase in p53 protein l
## Abstract X‐box binding protein 1 (XBP‐1) is stimulated by endoplasmic reticulum stress as part of the unfolded protein response (UPR), which can promote apoptosis or cell survival. Non‐conventional splicing, stimulated during the UPR, converts mRNA for “unspliced” XBP‐1U to “spliced” XBP‐1S mRNA